Brain CancerFeaturedNeurologyNeuroscience·November 21, 2022·6 min readPhase 3 Clinical Trial: Brain Cancer Vaccine Shows Promising ResultsResults of a phase three clinical trial of a novel brain cancer vaccine, DCVax-L, that uses a patient's stem cells to target cancer cells extend survival by many months to years for glioblastoma patients.Read More